Sibling's stem cells may free kidney patients from lifelong drugs
NCT ID NCT03707262
Summary
This study is testing a new treatment to help kidney transplant patients accept their new organ without needing lifelong anti-rejection medications. Patients receive a kidney and blood stem cells from a matched sibling, along with radiation and antibody therapy, aiming to train their immune system to tolerate the transplant. The goal is to see if patients can safely stop all immunosuppressive drugs one year after the transplant while keeping their new kidney healthy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.